Star Therapeutics has completed a Series D funding round, raising $125m aimed at supporting its pipeline progression. The ...
Cade, Telix Group Chief Medical Officer, said, "We are pleased to showcase our late-stage and next generation development programs and innovations in MedTech at EANM – the largest gathering of nuclear ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback